Invests in
Sectors:
Locations:
Min Investment:
$150,000.00Max Investment:
$20,000,000.00Target Investment:
$10,000,000.00
Education
Lists including Teddy
Work Experience
2023
Science Director
2024
Due diligence - Perform due diligence on investments in physical science / computing spaces. Focus sectors include energy generation (Acceleron Fusion), energy storage (Anthro Energy), and industrial transformation (Brimstone, Ferrum Technologies, Limelight Steel). Diligence process focuses on all aspects of the business plan, with particular depth in understanding technological differentiation and advantage. Thesis roadmapping - Develop firm investment theses around numerous topics within the umbrella of decarbonization, including energy generation/storage/transportation, application electrification, and industrial transformation. Deal sourcing - Leverage networks in VC / academia to source investment opportunities.
Science Advisor
2023 - 2024
2019 - 2022
Investment Associate
2019 - 2022
I performed deal sourcing, due diligence, and negotiations for investments in early-stage companies built on foundations of scientific innovation. I worked mainly with companies in the physical sciences, with a particular focus in energy storage and in applications where AI overlaps with the physical world, such as in computational material discovery and manufacturing automation.
2012 - 2019
Graduate Student Researcher
2012 - 2019
I worked with Prof. Sandra Troian in the Laboratory of Interfacial & Small Scale Transport {LIS2T} investigating several topics involving transport and deformation of liquids driven by surface stresses. My main project was a numerical study of the response of free liquid surfaces to strong applied electric fields with an aim to optimize a Liquid Metal Ion Source (LMIS) satellite thruster. Work was primarily computational but I was also involved in experimental aspects of designing the satellite thruster.
2014 - 2017
NASA Space Technology Research Fellow
2014 - 2017
2009 - 2012
Undergraduate Student Researcher
2009 - 2012
Optimized novel antibiotic susceptibility testing (AST) platform.